EPHA6 – Wikipedia

From Wikipedia, the free encyclopedia

Protein-coding gene in the species Homo sapiens

Ephrin type-A receptor 6 is a protein that in humans is encoded by the EPHA6 gene.[5][6]

EphA6 may serve an important role in breast carcinogenesis and may pose as a novel prognostic indicator and therapeutic target for breast cancer, particularly in patients with steroid receptor negative expression and HER‑2 overexpression[7]

References[edit]

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000080224 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000055540 – Ensembl, May 2017
  3. ^ “Human PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ “Mouse PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (December 2002). “The protein kinase complement of the human genome”. Science. 298 (5600): 1912–34. Bibcode:2002Sci…298.1912M. doi:10.1126/science.1075762. PMID 12471243. S2CID 26554314.
  6. ^ “Entrez Gene: EPHA6 EPH receptor A6”.
  7. ^ Zhou D, Ren K, Wang J, Ren H, Yang W, Wang W, et al. (April 2018). “Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer”. Oncology Letters. 15 (4): 5257–5263. doi:10.3892/ol.2018.7919. PMC 5840743. PMID 29552165.

Further reading[edit]

External links[edit]

  • Overview of all the structural information available in the PDB for UniProt: Q62413 (Mouse Ephrin type-A receptor 6) at the PDBe-KB.